161 related articles for article (PubMed ID: 7687120)
41. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV.
Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O
J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035
[No Abstract] [Full Text] [Related]
42. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
43. Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Hynes JB; Queener SF
Antimicrob Agents Chemother; 1995 Jan; 39(1):79-86. PubMed ID: 7695334
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
[TBL] [Abstract][Full Text] [Related]
45. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
Schmutzler W; Neukirch B; Ziesche R
Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of new 2,4-Diaminopyrido[2,3-d]pyrimidine and 2,4-Diaminopyrrolo[2,3-d]pyrimidine inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.
Rosowsky A; Chen H; Fu H; Queener SF
Bioorg Med Chem; 2003 Jan; 11(1):59-67. PubMed ID: 12467708
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of PCP episodes caused by Pneumocystis carinii with mutant dihydropteroate (DHPS) gene.
Visconti E; Ortona E; Margutti P; Marinaci S; Zolfo M; Celentano LP; Mencarini P; Siracusano A; Tamburrini E
J Eukaryot Microbiol; 1999; 46(5):135S. PubMed ID: 10519288
[No Abstract] [Full Text] [Related]
48. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
[TBL] [Abstract][Full Text] [Related]
49. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
50. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
51. 2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Papoulis AT; Queener SF
J Med Chem; 1997 Oct; 40(22):3694-9. PubMed ID: 9357537
[TBL] [Abstract][Full Text] [Related]
52. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
Suárez I; Roderus L; van Gumpel E; Jung N; Lehmann C; Fätkenheuer G; Hartmann P; Plum G; Rybniker J
Infection; 2017 Jun; 45(3):341-347. PubMed ID: 28303545
[TBL] [Abstract][Full Text] [Related]
53. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
54. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
Gangjee A; Zhu Y; Queener SF
J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
[TBL] [Abstract][Full Text] [Related]
55. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
Takahashi T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
[TBL] [Abstract][Full Text] [Related]
56. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
Nahimana A; Rabodonirina M; Zanetti G; Meneau I; Francioli P; Bille J; Hauser PM
J Infect Dis; 2003 Oct; 188(7):1017-23. PubMed ID: 14513422
[TBL] [Abstract][Full Text] [Related]
57. The effect of mafenide on dihydropteroate synthase.
Eagon RG; McManus AT
J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
[TBL] [Abstract][Full Text] [Related]
58. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.
Huang L; Beard CB; Creasman J; Levy D; Duchin JS; Lee S; Pieniazek N; Carter JL; del Rio C; Rimland D; Navin TR
J Infect Dis; 2000 Oct; 182(4):1192-8. PubMed ID: 10979917
[TBL] [Abstract][Full Text] [Related]
59. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.
Valerio A; Tronconi E; Mazza F; Fantoni G; Atzori C; Tartarone F; Duca P; Cargnel A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):521-8. PubMed ID: 17558331
[TBL] [Abstract][Full Text] [Related]
60. Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.
Ma L; Jia Q; Kovacs JA
Antimicrob Agents Chemother; 2002 Sep; 46(9):3101-3. PubMed ID: 12183283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
